|20.84||-0.33 / -1.56%|
As of 3:59pm ET
|20.77||-0.07 / -0.34%|
The 9 analysts offering 12-month price forecasts for Horizon Pharma PLC have a median target of 27.00, with a high estimate of 31.00 and a low estimate of 21.00. The median estimate represents a +29.56% increase from the last price of 20.84.
The current consensus among 9 polled investment analysts is to Buy stock in Horizon Pharma PLC. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.